Netherlands· NL-1030c6d7fe01

Dzuveo 30 microgram tabletten voor sublinguaal gebruik

A sufentanil product containing sufentanilcitraat, registered in Netherlands by Laboratoire Aguettant. The same ATC class is registered in 11 of our 19 countries.

ATC N01AH03

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about sufentanilcitraatAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Sufentanil is registered in 11 of 19 countries.

Countries holding a registration under ATC N01AH03 (sufentanil), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
7 of them publish a price we can compare per daily dose

Search sufentanil products by name

Sufentanil · ATC N01AH03

11 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Icelandprice
Ireland
Netherlands
Norwayprice
Polandprice
Switzerlandprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)

Active substance: SUFENTANILCITRAAT
Manufacturer: Laboratoire Aguettant
Country: Netherlands (NL)
ATC code: N01AH03
ATC class: Sufentanil
Defined daily dose: 30 mcg, P
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
EU/1/18/1284

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

216 interactions on record for sufentanil.

Graded by severity as the source publishes them — 20 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check sufentanil against other medicines How interaction checks work

Sufentanil · interactions on record

216 records

20 severe
158 moderate
38 info

Most severe, free to view

OndansetronA04AA01severe
GranisetronA04AA02severe
DolasetronA04AA04severe
PalonosetronA04AA05severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Sufentanil in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All sufentanil products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

Austria · Sufenta, Sufentanil Hameln
Belgium · Sufenta, Sufenta Forte
Cyprus · Sofentil
Czechia · Sontilen, Sufenta
Germany · Sufenta, Sufenta Epidural
Denmark · Sofentil, Sufenta
Spain · Safentil, Secufen
Finland · Sufenta, Sufenta Forte
France · Sufenta, Sufentanil Renaudin
United Kingdom (Northern Ireland) · Dzuveo
Croatia · Sofentil, Sufentanil Altamedics
Hungary · Sufentanil Hameln, Sufentanil Torrex
Iceland · Dzuveo, Sufenta
Italy · Disufen, Sufentanil Hameln
Liechtenstein · Dzuveo, Sufenta
Luxembourg · Sufenta, Sufenta Forte
Latvia · Sontilen
Malta · Sofentil
Norway · Dzuveo, Sufenta
Poland · Sufentanil Chiesi, Sufentanil Hameln
Portugal · Sontilen, Sufenta
Romania · Sofentil
Sweden · Sufenta, Sufentanil Hameln
Slovenia · Sufentanil Hameln
Slovakia · Sofentil, Sufentanil Chiesi

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/e85a6cf2-2e35-403a-9ef4-01e2f4ca8e45
GET /v1/drugs/e85a6cf2-2e35-403a-9ef4-01e2f4ca8e45?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet voor sublinguaal gebruik",
  "route": "Sublinguaal gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/dzuveo-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Sufentanil",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp120813",
  "excipients": [
    "CALCIUMWATERSTOFFOSFAAT 0-WATER (E 341)",
    "CROSCARMELLOSE  NATRIUM  (E 468)",
    "HYPROMELLOSE 2208 (Release controlling polymer), K4M (E 464)",
    "INDIGOKARMIJN ALUMINIUMLAK (E 132)",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MANNITOL (D-) (E 421)",
    "STEARINEZUUR (E 570)"
  ],
  "substances": [
    "SUFENTANILCITRAAT"
  ],
  "leaflet_url": null,
  "authorised_at": "2018/06/25",
  "procedure_number": "EMEA/H/C/004335",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/18/1284",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about sufentanil.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console